Upper Cross Syndrome and Neck Proprioception

NCT ID: NCT06801613

Last Updated: 2025-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-31

Study Completion Date

2025-10-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Correlation Between Upper Cross Syndrome and Neck Proprioception

Hypothesis:

No statistically significant relationship exists between upper cross syndrome and neck proprioception.

Study Design:

Randomized Controlled Trial

Participants:

Office workers (≥4h computer use/day) Age: 28-48 years Chronic nonspecific neck pain (\>3 months) Forward head posture (FHP) \<46° VAS score: 3-8 cm No cognitive impairments affecting participation

Exclusion Criteria:

Systemic, rheumatic, or neuromuscular diseases Neurological signs, spinal surgery, or recent physical therapy Missing ≥3 consecutive or 4 nonconsecutive sessions

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study Title:Correlation Between Upper Cross Syndrome and Neck Proprioception

Hypothesis:There will be no statistically significant relationship between upper cross syndrome and neck proprioception.

Methodology:

Study Design:Randomized controlled trial

Inclusion Criteria:

Office workers using a computer for at least 4 hours daily

Aged between 28 and 48 years

Neck pain (NP) between 3 and 8 cm on a visual analog scale (VAS) (0 = no pain, 10 = unbearable pain)

Chronic nonspecific neck pain lasting for more than 3 months

Forward head posture (FHP) less than 46°

Patients willing and able to participate in an exercise program safely without cognitive impairments that would limit participation

Exclusion Criteria:

Specific causes of NP (e.g., systemic, rheumatic, neuromuscular diseases)

Central or peripheral neurological signs

Cognitive impairment

History of spinal surgery

Physical therapy treatments in the last 6 months prior to baseline assessment

Participants missing at least three consecutive or four nonconsecutive sessions

Outcome Measures:

Spinal Curvature Assessment Using Spinal Mouse DeviceThe spinal mouse device is physically guided along the skin of the spine

Neck Pain MeasurementNP is evaluated using a 10-cm VAS, a widely used clinical tool for assessing pain treatment effectiveness.

Neck Disability Index (NDI)Disability is assessed using the NDI questionnaire.

Measurement of Cervical Range of Motion (CROM) Using a CROM

Assessment of Cervical Proprioception Using the CROM DeviceHead Reposition Accuracy Tests:

Neutral Head Position (NHP) Test: Measures the ability to actively reposition the head to the self-selected neutral position.

Target Head Position (THP) Test: Measures the ability to actively reposition the head to a previously demonstrated target position.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Upper Cross Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

Participants with UCS who do not receive the intervention (e.g., may receive standard care, education, or no treatment).

Intervention Group

Intervention Type OTHER

Group/Cohort Description: Participants with Upper Cross Syndrome (UCS) who undergo the prescribed exercise or treatment protocol.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention Group

Group/Cohort Description: Participants with Upper Cross Syndrome (UCS) who undergo the prescribed exercise or treatment protocol.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* office workers (using a computer at least 4 h),

* aged between 28 and 48 years,
* NP between 3 and 8 cm on a visual analog scale (VAS) (from 0 indicating no pain at all to 10 indicating unbearable pain),
* chronic nonspecific neck pain lasting for more than 3 months, and FHP less than 46° (Fathollahnejad et al., 2019).
* Patients willing and able to participate in an exercise program safely and without cognitive impairments that would limit their participation.

Exclusion Criteria

* specific causes of NP (e.g., systemic, rheumatic, neuromuscular diseases), central or peripheral neurological signs, cognitive impairment, spinal surgery, or physical therapy treatments in the last 6 months prior to the baseline assessment.
* Participants would be also excluded if they missed at least three consecutive or four nonconsecutive sessions (Fathollahnejad et al., 2019).
Minimum Eligible Age

28 Years

Maximum Eligible Age

48 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Omnia Mohamed Said El-Sayed

general practitioner

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Elsayed

Role: CONTACT

+20 100 219 5353

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/005030

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.